GeneMedicine Co., Ltd.
1 clinical trials · Sponsor
◉ Watch GeneMedicine Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors (NCT06265025) | GeneMedicine Co., Ltd. | 2024-02-20 |
Track GeneMedicine Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.